_id
690db481ccc777a4e85d0d59
Ticker
AZTR
Name
Azitra Inc
Exchange
NYSE MKT
Address
21 Business Park Drive, Branford, CT, United States, 06405
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://azitrainc.com
Description
Azitra, Inc., an early-stage clinical biopharmaceutical company, develops therapies for precision dermatology using engineered proteins and live biotherapeutic products to treat skin diseases. It develops ATR-12, a genetically modified strain of S. epidermidis, which is in Phase Ib clinical trial for treating Netherton syndrome, a skin disease. The company also develops ATR-04, a genetically modified strain of S. epidermidis that is in Phase 1/2 clinical trial for treating the papulopustular rash experienced by cancer patients undergoing epidermal growth factor receptor inhibitor; and ATR-01, an engineered recombinant human filaggrin protein for treating ichthyosis vulgaris, a skin disease. It has a collaboration with Bayer. The company was incorporated in 2014 and is based in Branford, Connecticut.
Last Close
0.3117
Volume
607263
Current Price
0.296
Change
-0.032
Last Updated
2026-01-20T16:09:06.814Z
Image
data:image/webp;base64,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
Ipo Date
2023-06-16T00:00:00.000Z
Market Cap
1868497
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Rating
4
Target Price
4.5
Strong Buy
0
Buy
1
Hold
0
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
0
Cost Of Revenue
112000
Gross Profit
-112000
Operating Expenses
2656484
Operating Income
-2768484
Interest Expense
372000
Pretax Income
-2764528
Net Income
-2764528
Eps
-0.671368098086505
Dividends Per Share
-
Shares Outstanding
5404968
Income Tax Expense
-
EBITDA
-2280528
Operating Margin
-
Total Other Income Expense Net
3956
Cash
1401878
Short Term Investments
-
Receivables
10366
Inventories
-
Total Current Assets
2230045
Property Plant Equipment
1071409
Total Assets
4300279
Payables
718476
Short Term Debt
580298
Long Term Debt
-
Total Liabilities
2021103
Equity
2279176
Bs_currency_symbol
USD
Depreciation
112000
Change In Working Capital
199697
Cash From Operations
-2444716
Capital Expenditures
3364
Cash From Investing
-41078
Cash From Financing
2841942
Net Change In Cash
356148
Cf_currency_symbol
USD
PE
0.0128
PB
0.5347787481089656
ROE
-121.29506453209406
ROA
-64.28717764591553
FCF
-2448080
Fcf Percent
-
Piotroski FScore
1
Health Score
38
Deep Value Investing Score
7.5
Defensive Investing Score
6.5
Dividend Investing Score
1.5
Economic Moat Investing Score
3.3
Garp Investing Score
1.5
Growth Investing Score
0.5
Momentum Investing Score
2
Net Net Investing Score
3.5
Quality Investing Score
2
Value Investing Score
7
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
112000
Quarters > 0 > income Statement > gross Profit
-112000
Quarters > 0 > income Statement > operating Expenses
2656484
Quarters > 0 > income Statement > operating Income
-2768484
Quarters > 0 > income Statement > interest Expense
372000
Quarters > 0 > income Statement > pretax Income
-2764528
Quarters > 0 > income Statement > net Income
-2764528
Quarters > 0 > income Statement > eps
-0.671368098086505
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
4117753
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-2280528
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
3956
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
1401878
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
10366
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
2230045
Quarters > 0 > balance Sheet > property Plant Equipment
1071409
Quarters > 0 > balance Sheet > total Assets
4300279
Quarters > 0 > balance Sheet > payables
718476
Quarters > 0 > balance Sheet > short Term Debt
580298
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
2021103
Quarters > 0 > balance Sheet > equity
2279176
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-2764528
Quarters > 0 > cash Flow > depreciation
112000
Quarters > 0 > cash Flow > change In Working Capital
199697
Quarters > 0 > cash Flow > cash From Operations
-2444716
Quarters > 0 > cash Flow > capital Expenditures
3364
Quarters > 0 > cash Flow > cash From Investing
-41078
Quarters > 0 > cash Flow > cash From Financing
2841942
Quarters > 0 > cash Flow > net Change In Cash
356148
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-0.671368098086505
Quarters > 0 > ratios > PB
0.5347787481089656
Quarters > 0 > ratios > ROE
-121.29506453209406
Quarters > 0 > ratios > ROA
-64.28717764591553
Quarters > 0 > ratios > FCF
-2448080
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
38
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
110622
Quarters > 1 > income Statement > gross Profit
-110622
Quarters > 1 > income Statement > operating Expenses
2760730
Quarters > 1 > income Statement > operating Income
-2871352
Quarters > 1 > income Statement > interest Expense
468
Quarters > 1 > income Statement > pretax Income
-2888993
Quarters > 1 > income Statement > net Income
-2888993
Quarters > 1 > income Statement > eps
-1.1818919316963812
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
2444380
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-2777905
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
-17641
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
1045730
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
78407
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
1799690
Quarters > 1 > balance Sheet > property Plant Equipment
1170318
Quarters > 1 > balance Sheet > total Assets
3956022
Quarters > 1 > balance Sheet > payables
635842
Quarters > 1 > balance Sheet > short Term Debt
303353
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
1727051
Quarters > 1 > balance Sheet > equity
2228971
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-2888993
Quarters > 1 > cash Flow > depreciation
110624
Quarters > 1 > cash Flow > change In Working Capital
-60370
Quarters > 1 > cash Flow > cash From Operations
-2815036
Quarters > 1 > cash Flow > capital Expenditures
36287
Quarters > 1 > cash Flow > cash From Investing
-36287
Quarters > 1 > cash Flow > cash From Financing
690343
Quarters > 1 > cash Flow > net Change In Cash
-2160980
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-1.1818919316963812
Quarters > 1 > ratios > PB
0.32460560500787133
Quarters > 1 > ratios > ROE
-129.6110626831843
Quarters > 1 > ratios > ROA
-73.02772835944795
Quarters > 1 > ratios > FCF
-2851323
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
38
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
117415
Quarters > 2 > income Statement > gross Profit
-117415
Quarters > 2 > income Statement > operating Expenses
3100238
Quarters > 2 > income Statement > operating Income
-3100238
Quarters > 2 > income Statement > interest Expense
1293
Quarters > 2 > income Statement > pretax Income
-3068345
Quarters > 2 > income Statement > net Income
-3068345
Quarters > 2 > income Statement > eps
-1.5514674053275181
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
1977705.1
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-2949637
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
31893
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
3206710
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
103046
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
3871554
Quarters > 2 > balance Sheet > property Plant Equipment
1089567
Quarters > 2 > balance Sheet > total Assets
5907891
Quarters > 2 > balance Sheet > payables
558924
Quarters > 2 > balance Sheet > short Term Debt
254103
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
1500267
Quarters > 2 > balance Sheet > equity
4407624
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-3068345
Quarters > 2 > cash Flow > depreciation
117415
Quarters > 2 > cash Flow > change In Working Capital
-149916
Quarters > 2 > cash Flow > cash From Operations
-3071762
Quarters > 2 > cash Flow > capital Expenditures
24839
Quarters > 2 > cash Flow > cash From Investing
-21686
Quarters > 2 > cash Flow > cash From Financing
1745439
Quarters > 2 > cash Flow > net Change In Cash
-1348009
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-1.5514674053275181
Quarters > 2 > ratios > PB
0.13281548280887842
Quarters > 2 > ratios > ROE
-69.61449070973386
Quarters > 2 > ratios > ROA
-51.93638474372665
Quarters > 2 > ratios > FCF
-3096601
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
41
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
7492500
Quarters > 3 > income Statement > cost Of Revenue
115748
Quarters > 3 > income Statement > gross Profit
-115748
Quarters > 3 > income Statement > operating Expenses
2318408
Quarters > 3 > income Statement > operating Income
-2434156
Quarters > 3 > income Statement > interest Expense
5612
Quarters > 3 > income Statement > pretax Income
-2384102
Quarters > 3 > income Statement > net Income
-2393133
Quarters > 3 > income Statement > eps
-2.088894607934789
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
1145645.64
Quarters > 3 > income Statement > income Tax Expense
9031
Quarters > 3 > income Statement > EBITDA
-2262745
Quarters > 3 > income Statement > operating Margin
-32.4879012345679
Quarters > 3 > income Statement > total Other Income Expense Net
50054
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
4554719
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
101896
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
5228290
Quarters > 3 > balance Sheet > property Plant Equipment
1205872
Quarters > 3 > balance Sheet > total Assets
7358802
Quarters > 3 > balance Sheet > payables
490255
Quarters > 3 > balance Sheet > short Term Debt
271243
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
1660504
Quarters > 3 > balance Sheet > equity
5698298
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-2393133
Quarters > 3 > cash Flow > depreciation
115748
Quarters > 3 > cash Flow > change In Working Capital
-341919
Quarters > 3 > cash Flow > cash From Operations
-2586201
Quarters > 3 > cash Flow > capital Expenditures
115532
Quarters > 3 > cash Flow > cash From Investing
-115532
Quarters > 3 > cash Flow > cash From Financing
-3782
Quarters > 3 > cash Flow > net Change In Cash
-2705515
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-2.088894607934789
Quarters > 3 > ratios > PB
0.0595109468546573
Quarters > 3 > ratios > ROE
-41.99732972898224
Quarters > 3 > ratios > ROA
-32.520687470596435
Quarters > 3 > ratios > FCF
-2701733
Quarters > 3 > ratios > Piotroski FScore
0
Quarters > 3 > ratios > fcf Percent
-0.3605916583249917
Quarters > 3 > health Score
33
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
7500000
Annuals > 0 > income Statement > cost Of Revenue
448235
Annuals > 0 > income Statement > gross Profit
7500000
Annuals > 0 > income Statement > operating Expenses
10992640000
Annuals > 0 > income Statement > operating Income
-10985140000
Annuals > 0 > income Statement > interest Expense
12160
Annuals > 0 > income Statement > pretax Income
-8958461
Annuals > 0 > income Statement > net Income
-8967492
Annuals > 0 > income Statement > eps
-15.799866789429144
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
567567.57
Annuals > 0 > income Statement > income Tax Expense
9031
Annuals > 0 > income Statement > EBITDA
-8498066
Annuals > 0 > income Statement > operating Margin
-146468.53333333333
Annuals > 0 > income Statement > total Other Income Expense Net
10976181539
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
4554719
Annuals > 0 > balance Sheet > short Term Investments
-4550164281
Annuals > 0 > balance Sheet > receivables
101896
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
5228290
Annuals > 0 > balance Sheet > property Plant Equipment
1205872
Annuals > 0 > balance Sheet > total Assets
7358802
Annuals > 0 > balance Sheet > payables
490255
Annuals > 0 > balance Sheet > short Term Debt
271243
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
1660504
Annuals > 0 > balance Sheet > equity
5698298
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-8967492
Annuals > 0 > cash Flow > depreciation
448235
Annuals > 0 > cash Flow > change In Working Capital
-441718
Annuals > 0 > cash Flow > cash From Operations
-10183740
Annuals > 0 > cash Flow > capital Expenditures
379246
Annuals > 0 > cash Flow > cash From Investing
-379246
Annuals > 0 > cash Flow > cash From Financing
13321716
Annuals > 0 > cash Flow > net Change In Cash
2758730
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-15.799866789429144
Annuals > 0 > ratios > PB
0.029482487704223254
Annuals > 0 > ratios > ROE
-157.37141160395615
Annuals > 0 > ratios > ROA
-121.8607594007829
Annuals > 0 > ratios > FCF
-10562986
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-1.4083981333333333
Annuals > 0 > health Score
33
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
686000
Annuals > 1 > income Statement > cost Of Revenue
425549
Annuals > 1 > income Statement > gross Profit
686000
Annuals > 1 > income Statement > operating Expenses
8136546
Annuals > 1 > income Statement > operating Income
-7450546
Annuals > 1 > income Statement > interest Expense
167726
Annuals > 1 > income Statement > pretax Income
-11266473
Annuals > 1 > income Statement > net Income
-11283781
Annuals > 1 > income Statement > eps
-326.9295636228462
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
34514.41
Annuals > 1 > income Statement > income Tax Expense
17308
Annuals > 1 > income Statement > EBITDA
-10673198
Annuals > 1 > income Statement > operating Margin
-1086.0854227405248
Annuals > 1 > income Statement > total Other Income Expense Net
-3815927
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
1795989
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
223474
Annuals > 1 > balance Sheet > inventories
-215219
Annuals > 1 > balance Sheet > total Current Assets
2535579
Annuals > 1 > balance Sheet > property Plant Equipment
1579037
Annuals > 1 > balance Sheet > total Assets
5115486
Annuals > 1 > balance Sheet > payables
897272
Annuals > 1 > balance Sheet > short Term Debt
322255
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
2202340
Annuals > 1 > balance Sheet > equity
2913146
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-11283781
Annuals > 1 > cash Flow > depreciation
425549
Annuals > 1 > cash Flow > change In Working Capital
-753429
Annuals > 1 > cash Flow > cash From Operations
-7362375
Annuals > 1 > cash Flow > capital Expenditures
318259
Annuals > 1 > cash Flow > cash From Investing
-318259
Annuals > 1 > cash Flow > cash From Financing
5983967
Annuals > 1 > cash Flow > net Change In Cash
-1696667
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-326.9295636228462
Annuals > 1 > ratios > PB
0.0035069527445586316
Annuals > 1 > ratios > ROE
-387.34004406232987
Annuals > 1 > ratios > ROA
-220.5808206688475
Annuals > 1 > ratios > FCF
-7680634
Annuals > 1 > ratios > Piotroski FScore
1
Annuals > 1 > ratios > fcf Percent
-11.196259475218659
Annuals > 1 > health Score
30
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
284000
Annuals > 2 > income Statement > cost Of Revenue
405977
Annuals > 2 > income Statement > gross Profit
284000
Annuals > 2 > income Statement > operating Expenses
9737604
Annuals > 2 > income Statement > operating Income
-9453604
Annuals > 2 > income Statement > interest Expense
251891
Annuals > 2 > income Statement > pretax Income
-10680366
Annuals > 2 > income Statement > net Income
-10680366
Annuals > 2 > income Statement > eps
-176.55557822119408
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
60492.94
Annuals > 2 > income Statement > income Tax Expense
-727798
Annuals > 2 > income Statement > EBITDA
-10022498
Annuals > 2 > income Statement > operating Margin
-3328.7338028169015
Annuals > 2 > income Statement > total Other Income Expense Net
-1226762
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
3492656
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
266208
Annuals > 2 > balance Sheet > inventories
216886
Annuals > 2 > balance Sheet > total Current Assets
4135883
Annuals > 2 > balance Sheet > property Plant Equipment
1963655
Annuals > 2 > balance Sheet > total Assets
7167443
Annuals > 2 > balance Sheet > payables
784687
Annuals > 2 > balance Sheet > short Term Debt
287384
Annuals > 2 > balance Sheet > long Term Debt
6600000
Annuals > 2 > balance Sheet > total Liabilities
43427753
Annuals > 2 > balance Sheet > equity
-36260310
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-10680366
Annuals > 2 > cash Flow > depreciation
405977
Annuals > 2 > cash Flow > change In Working Capital
310761
Annuals > 2 > cash Flow > cash From Operations
-8349469
Annuals > 2 > cash Flow > capital Expenditures
341011
Annuals > 2 > cash Flow > cash From Investing
-336761
Annuals > 2 > cash Flow > cash From Financing
4134624
Annuals > 2 > cash Flow > net Change In Cash
-4551606
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-176.55557822119408
Annuals > 2 > ratios > PB
-0.0004938156965563726
Annuals > 2 > ratios > ROE
29.454701297368942
Annuals > 2 > ratios > ROA
-149.0122209552277
Annuals > 2 > ratios > FCF
-8690480
Annuals > 2 > ratios > Piotroski FScore
1
Annuals > 2 > ratios > fcf Percent
-30.600281690140847
Annuals > 2 > health Score
31
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
110000
Annuals > 3 > income Statement > cost Of Revenue
84772
Annuals > 3 > income Statement > gross Profit
110000
Annuals > 3 > income Statement > operating Expenses
9331454
Annuals > 3 > income Statement > operating Income
-9221454
Annuals > 3 > income Statement > interest Expense
66968
Annuals > 3 > income Statement > pretax Income
-8939675
Annuals > 3 > income Statement > net Income
-8939675
Annuals > 3 > income Statement > eps
-147.7804682662142
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
60492.94
Annuals > 3 > income Statement > income Tax Expense
174450
Annuals > 3 > income Statement > EBITDA
-8787935
Annuals > 3 > income Statement > operating Margin
-8383.14
Annuals > 3 > income Statement > total Other Income Expense Net
281779
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
8044262
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
334178
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
8488729
Annuals > 3 > balance Sheet > property Plant Equipment
946681
Annuals > 3 > balance Sheet > total Assets
10201333
Annuals > 3 > balance Sheet > payables
717800
Annuals > 3 > balance Sheet > short Term Debt
-
Annuals > 3 > balance Sheet > long Term Debt
992019
Annuals > 3 > balance Sheet > total Liabilities
35967252
Annuals > 3 > balance Sheet > equity
-25765919
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-8939675
Annuals > 3 > cash Flow > depreciation
84772
Annuals > 3 > cash Flow > change In Working Capital
646350
Annuals > 3 > cash Flow > cash From Operations
-8067359
Annuals > 3 > cash Flow > capital Expenditures
652275
Annuals > 3 > cash Flow > cash From Investing
-652275
Annuals > 3 > cash Flow > cash From Financing
992862
Annuals > 3 > cash Flow > net Change In Cash
-7726772
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-147.7804682662142
Annuals > 3 > ratios > PB
-0.0006949455301788381
Annuals > 3 > ratios > ROE
34.69573509099365
Annuals > 3 > ratios > ROA
-87.63242019449811
Annuals > 3 > ratios > FCF
-8719634
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-79.2694
Annuals > 3 > health Score
30
Valuation > metrics > PE
0.0128
Valuation > metrics > PB
0.5347787481089656
Valuation > final Score
90
Valuation > verdict
73.2% Undervalued
Profitability > metrics > ROE
-121.29506453209406
Profitability > metrics > ROA
-123.96736388727582
Profitability > final Score
15
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.8867691656984805
Risk > metrics > Interest Coverage
-7.442161290322581
Risk > final Score
18
Risk > verdict
High
Liquidity > metrics > Current Ratio
1.7170385301830804
Liquidity > metrics > Quick Ratio
1.7170385301830804
Liquidity > final Score
93
Liquidity > verdict
Great
Prev Valuations > 0
70
Prev Valuations > 1
70
Prev Valuations > 2
70
Prev Profitabilities > 0
15
Prev Profitabilities > 1
15
Prev Profitabilities > 2
0
Prev Risks > 0
-24493
Prev Risks > 1
-9531
Prev Risks > 2
-1675
Prev Liquidities > 0
98
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T21:27:04.108Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-11-12
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
AfterMarket
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-0.67
Earnings History > 0 > eps Estimate
-0.77
Earnings History > 0 > eps Difference
0.1
Earnings History > 0 > surprise Percent
12.987
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-08-11
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
AfterMarket
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-1.2
Earnings History > 1 > eps Estimate
-1.4
Earnings History > 1 > eps Difference
0.2
Earnings History > 1 > surprise Percent
14.2857
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-05-14
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.23
Earnings History > 2 > eps Estimate
-
Earnings History > 2 > eps Difference
0
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2024-12-31
Earnings History > 3 > report Date
2025-02-24
Earnings History > 3 > date
2024-12-31
Earnings History > 3 > before After Market
BeforeMarket
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-2.09
Earnings History > 3 > eps Estimate
-3.33
Earnings History > 3 > eps Difference
1.24
Earnings History > 3 > surprise Percent
37.2372
Earnings History > 4 > period
2024-09-30
Earnings History > 4 > report Date
2024-11-12
Earnings History > 4 > date
2024-09-30
Earnings History > 4 > before After Market
AfterMarket
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-3.3
Earnings History > 4 > eps Estimate
-3.2
Earnings History > 4 > eps Difference
-0.1
Earnings History > 4 > surprise Percent
-3.125
Earnings History > 5 > period
2024-06-30
Earnings History > 5 > report Date
2024-08-12
Earnings History > 5 > date
2024-06-30
Earnings History > 5 > before After Market
AfterMarket
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-18.25
Earnings History > 5 > eps Estimate
-21.45
Earnings History > 5 > eps Difference
3.2
Earnings History > 5 > surprise Percent
14.9184
Earnings History > 6 > period
2024-03-31
Earnings History > 6 > report Date
2024-05-09
Earnings History > 6 > date
2024-03-31
Earnings History > 6 > before After Market
AfterMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-4.3596
Earnings History > 6 > eps Estimate
-
Earnings History > 6 > eps Difference
0
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2023-12-31
Earnings History > 7 > report Date
2024-03-15
Earnings History > 7 > date
2023-12-31
Earnings History > 7 > before After Market
AfterMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
27.97
Earnings History > 7 > eps Estimate
-35.96
Earnings History > 7 > eps Difference
63.93
Earnings History > 7 > surprise Percent
177.7809
Earnings History > 8 > period
2023-09-30
Earnings History > 8 > report Date
2023-11-14
Earnings History > 8 > date
2023-09-30
Earnings History > 8 > before After Market
AfterMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.16
Earnings History > 8 > eps Estimate
-
Earnings History > 8 > eps Difference
0
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2023-06-30
Earnings History > 9 > report Date
2023-06-30
Earnings History > 9 > date
2023-06-30
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-83.7803
Earnings History > 9 > eps Estimate
-
Earnings History > 9 > eps Difference
0
Earnings History > 9 > surprise Percent
-
Azitra, Inc., an early-stage clinical biopharmaceutical company, develops therapies for precision dermatology using engineered proteins and live biotherapeutic products to treat skin diseases. It develops ATR-12, a genetically modified strain of S. epidermidis, which is in Phase Ib clinical trial for treating Netherton syndrome, a skin disease. The company also develops ATR-04, a genetically modified strain of S. epidermidis that is in Phase 1/2 clinical trial for treating the papulopustular rash experienced by cancer patients undergoing epidermal growth factor receptor inhibitor; and ATR-01, an engineered recombinant human filaggrin protein for treating ichthyosis vulgaris, a skin disease. It has a collaboration with Bayer. The company was incorporated in 2014 and is based in Branford, Connecticut.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/ARisk Recap: How do insiders feel about TERN - Sell Signal & Reliable Entry Point Alerts baoquankhu1.vn
Read more →Is AZTR a top pick in the sector - 2025 Sector Review & Risk Controlled Stock Alerts bollywoodhelpline.com
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
BUY
Target Price:
$4.5
Analyst Picks
Strong Buy
0
Buy
1
Hold
0
Sell
0
Strong Sell
0
(Last Updated 2025-09-30)
Health Score
Price to Earnings Ratio (P/E)
-
Very High
Low ≥ 50
High ≤ 10
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Very Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Azitra Inc
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
-0.67
EPS Estimate
-0.77
EPS Difference
0.1
Surprise Percent
12.987%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.